An employee inspects tablets on the production line at a pharmaceutical plant of Lupin in the western state of Goa, India, June 9, 2017. REUTERS/Danish Siddiqui
An employee inspects tablets on the production line at a pharmaceutical plant of Lupin in the western state of Goa, India, June 9, 2017. REUTERS/Danish Siddiqui